Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Schwartz

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2003
Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyxRandal O Dull, Ramani Dinavahi, Lawrence Schwartz, et al.
Journal of Surgical Oncology|July 30, 2004
Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapyWaldemar F Carlo, Amanda J Hummer, Lawrence Schwartz, et al.
Journal of Medical Imaging (Bellingham, Wash.)|November 4, 2017
Interobserver variability in tumor contouring affects the use of radiomics to predict mutational statusQiao Huang, Lin Lu, Laurent Dercle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Phase II trial of bortezomib for patients with advanced renal cell carcinomaG Varuni Kondagunta, Beverly Drucker, Lawrence Schwartz, et al.
Life (Basel, Switzerland)|November 11, 2022
Chest CT for Breast Cancer DiagnosisElise Desperito, Lawrence Schwartz, Kathleen M Capaccione, et al.
Investigational New Drugs|December 28, 2007
Phase II trial of lenalidomide in patients with metastatic renal cell carcinomaPremal H Patel, G Varuni Kondagunta, Lawrence Schwartz, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 21, 2010
Kinetics of liver volume changes in the first year after portal vein embolizationDanton Corrêa, Lawrence Schwartz, William R Jarnagin, et al.
Clinical Genitourinary Cancer|May 27, 2008
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinomaDarren R Feldman, G Varuni Kondagunta, Lawrence Schwartz, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Automated framework for digital radiation dose index reporting from CT dose reportsGeorge Shih, Zheng Feng Lu, Ramin Zabih, et al.
Thrombosis and Haemostasis|September 28, 2012
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind studyJerry Powell, Uri Martinowitz, Jerzy Windyga, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2003
Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyxRandal O Dull, Ramani Dinavahi, Lawrence Schwartz, et al.
Journal of Surgical Oncology|July 30, 2004
Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapyWaldemar F Carlo, Amanda J Hummer, Lawrence Schwartz, et al.
Journal of Medical Imaging (Bellingham, Wash.)|November 4, 2017
Interobserver variability in tumor contouring affects the use of radiomics to predict mutational statusQiao Huang, Lin Lu, Laurent Dercle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Phase II trial of bortezomib for patients with advanced renal cell carcinomaG Varuni Kondagunta, Beverly Drucker, Lawrence Schwartz, et al.
Life (Basel, Switzerland)|November 11, 2022
Chest CT for Breast Cancer DiagnosisElise Desperito, Lawrence Schwartz, Kathleen M Capaccione, et al.
Investigational New Drugs|December 28, 2007
Phase II trial of lenalidomide in patients with metastatic renal cell carcinomaPremal H Patel, G Varuni Kondagunta, Lawrence Schwartz, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 21, 2010
Kinetics of liver volume changes in the first year after portal vein embolizationDanton Corrêa, Lawrence Schwartz, William R Jarnagin, et al.
Clinical Genitourinary Cancer|May 27, 2008
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinomaDarren R Feldman, G Varuni Kondagunta, Lawrence Schwartz, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Automated framework for digital radiation dose index reporting from CT dose reportsGeorge Shih, Zheng Feng Lu, Ramin Zabih, et al.
Thrombosis and Haemostasis|September 28, 2012
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind studyJerry Powell, Uri Martinowitz, Jerzy Windyga, et al.
Pageof 9